NIGP 115: Biochemicals, Research

NIGP 115 Biochemicals, Research is a Class code encompassing laboratory testing and analysis services that state and local governments procure to monitor and ensure compliance with environmental and public health standards. Recent solicitations show municipal water utilities, environmental agencies, and wastewater treatment plants buying microbial and chemical analysis of drinking water, wastewater, stormwater, recycled water, and related samples—work that requires EPA or state-equivalent accreditation (ELAP, TNI, ISO) and certified laboratory infrastructure. The scope extends to specialized microbial source tracking using polymerase chain reaction assays, DNA analysis for forensic and drug screening applications, and chemical disinfectant components such as sodium hypochlorite and zinc orthophosphate for water treatment systems. Issuing bodies include municipal water and wastewater departments, city environmental divisions, state departments of public safety and parks, water utilities, and regional water authorities. Santa Monica Water Resources Division, Tucson Water, Meriden Water Department, and the Texas Comptroller of Public Accounts (procuring on behalf of the Texas Department of Public Safety and Parks and Wildlife) appear as repeat buyers or high-volume users of these services across the recent pipeline.

Geographic activity concentrates in California, Arizona, Connecticut, Texas, Utah, and Pennsylvania, with notable recent solicitations spanning the West Coast to the Mid-Atlantic. Representative current opportunities include Santa Monica's ITB for laboratory analysis of treated drinking water, raw groundwater, wastewater treatment plant process flows, and urban runoff (Solicitation 4520, due October 21, 2026), Meriden Water Department's ITB for comprehensive laboratory testing of 56 frequent and 11 infrequent water-quality parameters under a two-year term with two-year renewal options (ITB B026-58, due June 12, 2026), and the Texas Comptroller's IFB for proprietary DNA sequencing kits, genetic analyzer components, and drug-screening reagents from manufacturers including Life Technologies, Promega, and Immunalysis (IFB 304T-27-175A1.1, due October 20, 2026). Successful vendors in this code typically carry multiple state and EPA certifications, maintain specialized equipment calibration, guarantee quick turnaround on results (often within 7–10 business days), provide sample kits and pickup logistics, and meet minimum insurance thresholds of $1 million general liability per occurrence.